144 ·Filed Jun 15, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 6/10
Horizonweeks Processed3mo ago SEC0001950047-26-006156
Form 144 — notice of proposed sale of securities
Actionable Insight ▼ Bearish

The sustained CEO selling pattern is a strong bearish signal that warrants caution. Traders should monitor for any negative pre-announcement or clinical data readout that may have prompted the insider to reduce exposure. If the selling continues at this pace, it could pressure the stock further despite bullish analyst consensus.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ANAB ▼ -4.25% at T+60d
SHORT call ✓ call won +4.25% · α vs SPY +5.25% · entry $57.61 → $55.16
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
-1.46%
call +1.46% · α +0.21%
$56.77
settled 4mo ago
T+5d
+3.16%
call -3.16% · α -5.39%
$59.43
settled 3mo ago
T+20d
+8.51%
call -8.51% · α -8.31%
$62.51
settled 3mo ago
T+60d
-4.25%
call +4.25% · α +5.25%
$55.16
settled 22d ago

Price Chart

Loading chart...

Executive Summary

CEO Dennis Mulroy filed a Form 144 notice of intent to sell 20,000 shares of ANAB common stock, valued at approximately $1.15 million, through Morgan Stanley. This filing is part of a sustained selling pattern: Mulroy has sold shares on nearly every trading day from May 15 through June 15, 2026, totaling over 296,000 shares and roughly $16.7 million in proceeds. The persistent insider selling at a $1.6B market-cap biotech with strong analyst consensus (94% bullish) is a notable bearish signal, suggesting management may be taking profits ahead of potential catalysts or de-risking personal exposure.

Key Facts

  • CEO Dennis Mulroy filed Form 144 to sell 20,000 shares (~$1.15M) on June 15, 2026.
  • Mulroy has sold shares on 18 of the last 22 trading days (May 15–June 15, 2026), totaling ~296,000 shares and ~$16.7M in proceeds.
  • The proposed sale is via a cash exercise of stock options, with the shares acquired from the issuer.
  • ANAB has a $1.6B market cap and 94% analyst bullish consensus (6 Strong Buy, 10 Buy, 1 Hold).
  • Top institutional holders include BlackRock ($93M), Morgan Stanley ($55M), and State Street ($55M).

Financial Impact

CEO selling ~$1.15M in a single notice, part of a sustained ~$16.7M selling wave over 22 trading days; represents a material reduction in insider ownership.

insider ownershipshare count

Risk Factors

  • CEO selling may signal undisclosed negative developments or a lack of confidence in near-term prospects.
  • Continued insider selling could erode investor sentiment and offset positive analyst ratings.
  • The selling may be for personal financial planning, but the volume and consistency are unusual for a routine diversification strategy.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006156
Document: 0001950047-26-006156-index.html0001950047-26-006156
Document: 0001950047-26-006156.txt0001950047-26-006156
24 reports for ANAB
Performance horizon
65% Hit rate 11 of 17 directional calls best @ T+60▲ +41.26%Mar 3, 2026
Filters
Rows
Reports for ANAB — sortable, filterable
TypeNow
Aug 12, 2026
7w ago
Institutional Cluster
BULLISH ★ 5/10
$56.02 $53.87▼ −3.84%▼ −2.09%$48.53 (−13.37%)
Jun 29, 2026
13w ago
144
BEARISH ★ 6/10
$67.50 $53.61▲ +20.58%▲ +19.55%$48.53 (+28.10%)
Jun 29, 2026
13w ago
DEFA14A
NEUTRAL ★ 2/10
$67.50 $53.61▼ −20.58%▼ −19.55%$48.53 (−28.10%)
Jun 26, 2026
13w ago
144
BEARISH ★ 6/10
$65.97 $54.15▲ +17.92%▲ +17.64%$48.53 (+26.44%)
Jun 22, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$59.43 $50.29▼ −15.38%▼ −16.54%$48.53 (−18.34%)
Jun 17, 2026
15w ago
144
BEARISH ★ 5/10
$57.51 $54.15▲ +5.84%▲ +6.38%$48.53 (+15.61%)
Jun 15, 2026
15w ago
144
BEARISH ★ 6/10
$57.61 $62.51▼ −8.51%▼ −8.31%$48.53 (+15.76%)
Jun 11, 2026
16w ago
144
BEARISH ★ 6/10
$56.07 $66.39▼ −18.41%▼ −16.63%$48.53 (+13.45%)
Jun 10, 2026
16w ago
144
BEARISH ★ 5/10
$54.24 $66.59▼ −22.77%▼ −20.88%$48.53 (+10.53%)
Jun 8, 2026
16w ago
144
BEARISH ★ 5/10
$51.63 $67.33▼ −30.40%▼ −28.95%$48.53 (+6.00%)
Showing 10 of 24

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access